|
Clinical trials Methodology/study design
Citations 11-20 of 93 total displayed.
|
Past content
(since Jan 2001):
|
- EDITORIALS
Brain atrophy as an outcome measure for multiple sclerosis clinical trials: A "no-brainer"?
- Richard A. Rudick and Elizabeth Fisher
Neurology 2009; 72: 586-587.
[Full text]
[PDF]
- ARTICLES
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis
- D. R. Altmann, B. Jasperse, F. Barkhof, K. Beckmann, M. Filippi, L. D. Kappos, P. Molyneux, C. H. Polman, C. Pozzilli, A. J. Thompson, K. Wagner, T. A. Yousry, and D. H. Miller
Neurology 2009; 72: 595-601.
[Abstract]
[Full text]
[PDF]
- ARTICLES
How redesigning AD clinical trials might increase study partners’ willingness to participate
- Jason Karlawish, Mark S. Cary, Jonathan Rubright, and Tom TenHave
Neurology 2008; 71: 1883-1888.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Why surrogate consent is important: A role for data in refining ethics policy and practice
- Donna T. Chen
Neurology 2008; 71: 1562-1563.
[Full text]
[PDF]
- ARTICLES
How important is surrogate consent for stroke research?
- M. L. Flaherty, J. Karlawish, J. C. Khoury, D. Kleindorfer, D. Woo, and J. P. Broderick
Neurology 2008; 71: 1566-1571.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Dose comparison trial of sustained-release fampridine in multiple sclerosis
- A. D. Goodman, T. R. Brown, J. A. Cohen, L. B. Krupp, R. Schapiro, S. R. Schwid, R. Cohen, L. N. Marinucci, A. R. Blight For the Fampridine MS-F202 Study Group
Neurology 2008; 71: 1134-1141.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
You get what you measure: Evaluating endpoints in MS clinical trials
- Ruth Ann Marrie
Neurology 2008; 71: 620-621.
[Full text]
[PDF]
- VIEWS AND REVIEWS
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
- Nico J. Diederich and Christopher G. Goetz
Neurology 2008; 71: 677-684.
[Abstract]
[Full text]
[PDF]
- ARTICLES
SCA Functional Index: A useful compound performance measure for spinocerebellar ataxia
- T. Schmitz-Hübsch, P. Giunti, D. A. Stephenson, C. Globas, L. Baliko, F. Saccà, C. Mariotti, M. Rakowicz, S. Szymanski, J. Infante, B.P.C. van de Warrenburg, D. Timmann, R. Fancellu, R. Rola, C. Depondt, L. Schöls, E. Zdzienicka, J. -S. Kang, S. Döhlinger, B. Kremer, B. Melegh, A. Filla, and T. Klockgether
Neurology 2008; 71: 486-492.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
The muddle of mycophenolate mofetil in myasthenia
- Michael Benatar and Lewis P. Rowland
Neurology 2008; 71: 390-391.
[Full text]
[PDF]
|
|
